My bookmarksSign up free

Regulation (EU) 2017/746 Article 57

Regulation (EU) 2017/746 Article 57

General requirements regarding performance studies

Article 57

1.   The manufacturer shall ensure that a device for performance study complies with the general safety and performance requirements set out in Annex I apart from the aspects covered by the performance study and that, with regard to those aspects, every precaution has been taken to protect the health and safety of the patient, user and other persons. 2.   Where appropriate, performance studies shall be performed in circumstances similar to the normal conditions of use of the device. 3.   Performance studies shall be designed and conducted in such a way that the rights, safety, dignity and well-being of the subjects participating in such performance studies are protected and prevail over all other interests and the data generated are scientifically valid, reliable and robust. Performance studies, including performance studies that use left-over samples, shall be conducted in accordance with applicable law on data protection.

Read the full instrument → · Read this in context: CHAPTER VI — CLINICAL EVIDENCE, PERFORMANCE EVALUATION AND PERFORMANCE STUDIES →

Other provisions in CHAPTER VI — CLINICAL EVIDENCE, PERFORMANCE EVALUATION AND PERFORMANCE STUDIES

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 57 of Regulation (EU) 2017/746 (LawPlayer, data as of 2026-07-04)

© European Union, https://eur-lex.europa.eu, 1998-2026. Reuse authorised under Commission Decision 2011/833/EU, provided the source is acknowledged.

What to look at next